PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 17.50 | 5.3% | 347.50 | 335.00 | 360.00 | 347.50 | 345.00 | 345.00 | 10,231 | 14:00:01 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -15.1 | -33.0 | - | 175 |
Faron Pharmaceuticals Oy (FARN) News Headlines
Faron Pharmaceuticals Oy News
| Date | Time | Source | Headline |
|---|---|---|---|
| 29/3/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Appointment of a Broker |
| 25/3/2021 | 14:49 | ALNC |  TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout |
| 25/3/2021 | 07:45 | UKREG | Faron Pharmaceuticals Oy Exercise of Options |
| 25/3/2021 | 07:30 | UKREG | Faron Pharmaceuticals Oy Notice of Faron Pharmaceuticals Ltd's AGM |
| 25/3/2021 | 07:15 | UKREG | Faron Pharmaceuticals Oy Faron's Annual Report 2020 published |
| 25/3/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Financial statement January 1 to December 31 2020 |
| 22/3/2021 | 09:32 | ALNC | Faron Pharmaceuticals shares boosted by positive data on cancer drug |
| 22/3/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Bexmarilimab (Clevegen) development update |
| 11/3/2021 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Faron to Present at Oppenheimer Conference |
| 02/3/2021 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Faron to Present at H.C. Wainwright Conference |
1 Year Faron Pharmaceuticals Oy Chart |
Intraday Faron Pharmaceuticals Oy Chart |
